Advertisement

Topics

FDA Advisory Committee Does Not Recommend Approval Of Sirukumab For The Treatment Of Moderately ...

16:49 EDT 2 Aug 2017 | BioMedReports - Blog

"We appreciate the advisory committee's thoughtful review and discussion of the sirukumab efficacy and safety data during today's meeting. While the committee voted unanimously in

Read more...

Original Article: FDA Advisory Committee Does Not Recommend Approval Of Sirukumab For The Treatment Of Moderately ...

NEXT ARTICLE

More From BioPortfolio on "FDA Advisory Committee Does Not Recommend Approval Of Sirukumab For The Treatment Of Moderately ..."

Quick Search
Advertisement